Protagonist Therapeutics (PTGX) – Downgrades
-
UPDATE: JPMorgan Downgrades Protagonist Therapeutics (PTGX) to Neutral
-
Northland Capital Markets Downgrades Protagonist Therapeutics (PTGX) to Market Perform, Following Clinical Business Update
-
-
Back to PTGX Stock Lookup